期刊文献+

重组人内抑素抑制创面瘢痕增生的实验研究 被引量:4

Study of the inhibitory effects of recombinant human endostatin on hypertrophic scars
下载PDF
导出
摘要 目的观察重组人内抑素(rhEndostatin)对兔耳瘢痕增生的抑制作用,探讨其部分作用机制。方法建立兔耳增生性瘢痕(HS)模型,瘢痕块内局部注射rhEndostatin(1.25、2.5、5 g/L),观察瘢痕大体形态及组织学变化,免疫组织化学检测瘢痕组织Ⅰ、Ⅲ型胶原表达,电镜观察瘢痕组织成纤维细胞凋亡。结果与模型组和生理盐水组比较,2.5 g/L和5 g/L rhEndostatin组瘢痕平坦,面积减小,质地变软,瘢痕增生指数降低(P<0.05);微血管密度降低(P<0.05);Ⅰ、Ⅲ型胶原表达水平降低(P<0.05);成纤维细胞凋亡。结论rhEndostatin可抑制HS形成,该作用可能与rhEndostatin抑制血管生成,进而促进增生性瘢痕成纤维细胞(HSFs)凋亡,减少胶原的产生与沉积有关。 Objective To investigate the therapeutic effects of recombinant human endostatin ( rhEndostatin ) on hypertrophic scar ( HS ) and explore the possible mechanism of action involved. Methods A rabbit ear model with hypertrophic scars was established. Recombinant human endostatin injections were applied to the scars of the experimental group topically in different concentrations (1. 25, 2. 5, 5 g/L). The changes of macroscopic characteristics of scars were examined. Light microscopy and transmission electron microscopy were used for histomorphometric analysis. The levels of collagens Ⅰ and Ⅲ were detected by immunohistochemistry. Results Compared with physiological saline group and model group, group treated with rhEndostatin 2. 5 g/L and 5. 0 g/L showed significant reduction in height, volume and hardness, it resulted in a statistically significant reduction in the scar elevation index, the microvessel density and the expression of type Ⅰ and Ⅲ collagens (P〈0. 05). An observation under transmission electron microscopy revealed that some fibroblasts nucleus ruptured and disintegrated and apoptotic body were observed in rhEndostatin 5 g/L group, but seldom found in triamcinolone group. Conclusion The findings of this study suggest that rhEndostatin has a markedly inhibitive effect on the formation of hypertrophic scar. It suppresses angiogenesis, and subsequently promotes HSFs apoptosis and reduces the overproduction and excessive deposition of collagen may account for this result.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第7期891-896,共6页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金面上项目(编号:81171819 81272107) 安徽高校省级自然科学研究项目(编号:KJ2012Z166)
关键词 重组人内抑素 增生性瘢痕 recombinant human endostatin hypertrophic scar
  • 相关文献

参考文献15

  • 1Rahmani-Neishaboor E, Yau F M, Jalili R, et al. Improvement of hypertrophic scarring by using topical anti-fibrogenic/anti-inflam- matory factors in a rabbit ear model [ J ]. Wound Repair Regen, 2010, 18(4) :401 -8.
  • 2Lee D W, Ku S K, Cho H J, et al. Effects of NoscarnaTM on hy- pertrophic scarring in the rabbit ear model: histopathological as- pects[J]. Arch Pharrn Res, 2012, 35( 11 ) :1999 -2006.
  • 3Shridharani S M, Magarakis M, Manson P N, et al. The emerging role of antineoplastic agents in the treatment of keloids and hyper- trophic scars : a review[ J]. Ann Plast Surg,2010,64 (3) : 355 - 61.
  • 4Bloemen M C, van der Veer W M, Ulrich M M, et al. Prevention and curative management of hypertrophic scar formation [ J ]. Bums,2009,35 (4) : 463 - 75.
  • 5O'Reilly M S, Boehm T, Shing Y, et al. Endostatin: an endoge- nous inhibitor of angiogenesis and tumor growth [ J]. Cell, 1997, 88(2) :277 -85.
  • 6Gabriel V. Hypertrophic scar[J]. Phys Med Rehabil Clin N Am, 2011, 22(2) :301 - 10.
  • 7Tollefson T T, Kamangar F, Aminpour S, et al. Comparison of ef- fectiveness of silicone gel sheeting with microporous paper tape in the prevention of hypertrophic scarring in a rabbit model [ J ]. Arch Facial Plast Surg, 2012, 14 ( 1 ) :45 - 51.
  • 8Morris D E, Wu L, Zhao L L, et al. Acute and chronic animal models for excessive dermal scarfing: quantitative studies [ J ]. Plast Reconstr Surg, 1997, 100 ( 3 ) :674 - 81.
  • 9Yang G P, Lim L J, Phan T T, et al. From scarless fetal wounds to keloids : molecular studies in wound healing [ J ]. Wound Re- pair Regen, 2003, 11(6) :411 -8.
  • 10Zhu Z, Ding J, Shankowsky H A, et al. The molecular mecha- nism of hypertrophic scar [ J ]. J Cell Commun Signal, 2013, 7 (4) :239 -52.

二级参考文献29

  • 1陈伟,付小兵,王海滨,周岗,韩冰,李海红,孙同柱,盛志勇.增生性瘢痕中凋亡相关基因转录的变化[J].中华实验外科杂志,2005,22(2):235-237. 被引量:13
  • 2Ladak A,Tredget EE. Pathophysiology and management of the burn scar[J].Clinics in Plastic Surgery,2009,(04):661-674.doi:10.1016/j.cps.2009.05.014.
  • 3Sidgwick GP,Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring[J].Journal of the European Academy of Dermatology and Venereology,2011,(04):418-432.
  • 4Junker JP,Kratz C,Tollh ck A. Mechanical tension stimulates the transdifferentiation of fibroblasts into myofibroblasts in human burn scars[J].Burns:Journal of the International Society For Burn Injuries,2008,(07):942-946.doi:10.1016/j.burns.2008.01.010.
  • 5Kose O,Waseem A. Keloids and hypertrophic scars:are they two different sides of the same coin[J].Dermatologic Surgery,2008,(03):336-346.doi:10.1111/j.1524-4725.2007.34067.x.
  • 6Bock O,Yu H,Zitron S. Studies of transforming growth factors beta 1-3 and their receptors Ⅰ and Ⅱ in fibroblast of keloids and hypertrophic scars[J].Acta Dermato Venereologica,2005,(03):216-220.
  • 7Abdou AG,Maraee AH,Al-Bara AM. Immunohistochemical expression of TGF-betal in keloids and hypertrophic scars[J].AmJ Dermatopathol,2011,(01):84-91.
  • 8Wei YJ,Yan XQ,Ma L. Oleanolic acid inhibits hypertrophic scarring in the rabbit ear model[J].Clinical and Experimental Dermatology,2011.
  • 9Gauglitz GG,Korting HC,Pavicic T. Hypertrophic scarring and keloids:pathomechanisms and current and emerging treatment strategies[J].Molecular Medicine,2011,(1 2):113-125.doi:10.2119/molmed.2009.00153.
  • 10Cutroneo KR. TGF-beta-induced fibrosis and SMAD signaling:oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring[J].Wound Repair and Regeneration,2007,(Sup 1):S54-S60.

共引文献4

同被引文献48

  • 1李伏燕,吴立兵,刘刚.三种方法治疗瘢痕疙瘩疗效分析[J].中华临床医师杂志(电子版),2011,5(8):2418-2419. 被引量:5
  • 2夏丽娟,陈飞虎,黄学应,刘永靖,李俊.重组人内抑素对佐剂性关节炎大鼠滑膜组织血管内皮细胞生长因子表达的影响[J].中国临床药理学与治疗学,2006,11(7):760-763. 被引量:13
  • 3Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomeehanisms and current and emerging treatment strategies[J]. Moi Med, 9011, 17(1-2) : 113-125.
  • 4O' Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [ J ]. Cell.1997, 88(2) : 277-285.
  • 5Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarfing: quantitative studies[J]. Plast Reconstr Surg, 1997, 100(3) : 674-681.
  • 6Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring [ J ]. J Eur Acad Dermatol Venereol, 2012, 26(2) : 141-152.
  • 7Gerd G Gauglitz. Management of keloids and hypertrophic scars: current and emerging options[ J]. Clin Cosmet Investig Dermatol, 2013, (6) : 103-114.
  • 8Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response [J]. FASEB J, 2004, 18(7) : 816-827.
  • 9Shi HX, Cai L, Lin BB, et al. The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo[ J]. PLoS One, 2013, 8(4) : e59966.
  • 10Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing[ J]. Wound Repair Regen, 2008, 16(5) :585-601.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部